• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促进甲状腺癌的进展,加速 G1/S 期过渡并抑制细胞凋亡。

Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis.

机构信息

Department of Surgical Oncology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang, China.

Department of Operating Theatre, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.

出版信息

Dis Markers. 2022 Aug 3;2022:2562595. doi: 10.1155/2022/2562595. eCollection 2022.

DOI:10.1155/2022/2562595
PMID:35968508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9365581/
Abstract

BACKGROUND

Thyroid carcinoma (TC) is an increasingly common malignancy of endocrine organs, and its most frequently encountered histotype is papillary thyroid cancer (PTC). Identifying new potential gene alterations is important for completely elucidating the mechanism of PTC initiation and progression. Thus, we performed whole transcriptome sequence analysis (RNA-seq) on 79 PTC tissue samples and paired adjacent nontumor tissue samples to study the molecular mechanism of TC tumorigenesis and progression further. The results of RNA-seq analysis showed that spectrin beta, nonerythrocytic 2 (), was markedly overexpressed in PTC tissues relative to that in the paired nontumor tissues. Additionally, the analysis results for 502 PTC samples and 58 nontumor thyroid samples from The Cancer Genome Atlas dataset were consistent with our RNA-seq results. However, the molecular mechanisms and function of in TC progression remain unknown.

METHODS

We examined gene expression in 48 papillary thyroid tumor tissues and paired adjacent normal thyroid tissues by using qRT-PCR. expression in the TC cell lines was silenced by small interfering RNA. Then, the transfected TC cells were used to investigate the in vitro function of .

RESULT

The expression of was significantly upregulated in our RNA-seq cohort, our local validated cohort, and TCGA RNA-seq cohort. The results of the in vitro experiment revealed that in TC cell lines, downregulation considerably suppressed tumor cell proliferation, the cell cycle, migration, colony formation, and invasion and induced cell apoptosis. Furthermore, the protein levels of CCNE2, CDK2, CDK4, and Bcl-2 were downregulated, and those of P21, Bax, cleaved caspase-8, and cleaved caspase-3 had increased in transfected TC cells relative to in control TC cells.

CONCLUSION

The downregulation of caused apoptosis and retarded G1/S cell cycle transition in TC cells. Thus, may be a good candidate gene for TC diagnosis and therapy.

摘要

背景

甲状腺癌(TC)是内分泌器官中一种日益常见的恶性肿瘤,其最常见的组织学类型是甲状腺乳头状癌(PTC)。确定新的潜在基因改变对于完全阐明 PTC 发生和进展的机制非常重要。因此,我们对 79 例 PTC 组织样本和配对的相邻非肿瘤组织样本进行了全转录组序列分析(RNA-seq),以进一步研究 TC 肿瘤发生和进展的分子机制。RNA-seq 分析的结果表明, spectrin beta, nonerythrocytic 2 ( ) 在 PTC 组织中相对于配对的非肿瘤组织明显过表达。此外,来自癌症基因组图谱数据集的 502 例 PTC 样本和 58 例非肿瘤甲状腺样本的分析结果与我们的 RNA-seq 结果一致。然而, 在 TC 进展中的分子机制和功能仍然未知。

方法

我们使用 qRT-PCR 检测了 48 例甲状腺乳头状瘤组织和配对的相邻正常甲状腺组织中的 基因表达。用小干扰 RNA 沉默 TC 细胞系中的 表达。然后,用转染的 TC 细胞来研究 的体外功能。

结果

在我们的 RNA-seq 队列、我们的本地验证队列和 TCGA RNA-seq 队列中, 的表达均显著上调。体外实验的结果表明,在 TC 细胞系中, 下调显著抑制肿瘤细胞增殖、细胞周期、迁移、集落形成和侵袭,并诱导细胞凋亡。此外,转染的 TC 细胞中 CCNE2、CDK2、CDK4 和 Bcl-2 的蛋白水平下调,而 Bax、cleaved caspase-8 和 cleaved caspase-3 的蛋白水平上调。

结论

下调导致 TC 细胞凋亡和 G1/S 细胞周期阻滞。因此, 可能是 TC 诊断和治疗的一个良好候选基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/d4463568bdf8/DM2022-2562595.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/f8f677e727dc/DM2022-2562595.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/37b914df9d87/DM2022-2562595.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/696f651a99f4/DM2022-2562595.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/6c7878a40e41/DM2022-2562595.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/e21b145d5222/DM2022-2562595.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/d4463568bdf8/DM2022-2562595.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/f8f677e727dc/DM2022-2562595.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/37b914df9d87/DM2022-2562595.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/696f651a99f4/DM2022-2562595.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/6c7878a40e41/DM2022-2562595.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/e21b145d5222/DM2022-2562595.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09ab/9365581/d4463568bdf8/DM2022-2562595.006.jpg

相似文献

1
Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis.促进甲状腺癌的进展,加速 G1/S 期过渡并抑制细胞凋亡。
Dis Markers. 2022 Aug 3;2022:2562595. doi: 10.1155/2022/2562595. eCollection 2022.
2
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.沉默长链非编码 RNA 烟酰胺核苷酸转氢酶反义 RNA 1 通过靶向 miR-199a-5p 抑制甲状腺乳头状癌细胞增殖、迁移和侵袭并促进细胞凋亡。
Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20.
3
Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.清道夫受体 A 家族成员 5 通过上皮-间充质转化与甲状腺癌细胞系的进展相关。
Cell Biochem Funct. 2020 Mar;38(2):158-166. doi: 10.1002/cbf.3455. Epub 2020 Jan 27.
4
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.生长相关蛋白 43 通过上皮-间充质转化促进甲状腺癌细胞系的进展。
J Cell Mol Med. 2019 Dec;23(12):7974-7984. doi: 10.1111/jcmm.14460. Epub 2019 Sep 30.
5
Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway.通过 PI3K/AKT 信号通路促进分化型甲状腺癌的进展。
Curr Cancer Drug Targets. 2024;24(2):220-229. doi: 10.2174/1568009622666220908092506.
6
The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.长链非编码 RNA UNC5B-AS1 促进甲状腺乳头状癌细胞系的增殖、迁移和侵袭。
Hum Cell. 2019 Jul;32(3):334-342. doi: 10.1007/s13577-019-00242-8. Epub 2019 Feb 25.
7
A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.一种新的长链非编码 RNA n384546 通过作为 miR-145-5p 的竞争性内源性 RNA 来调节 AKT3,促进甲状腺乳头状癌的进展和转移。
Cell Death Dis. 2019 Jun 3;10(6):433. doi: 10.1038/s41419-019-1637-7.
8
LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.含LEM结构域蛋白1通过激活Wnt/β-连环蛋白信号通路和上皮-间质转化促进甲状腺癌细胞增殖和迁移。
Oncol Lett. 2021 Jun;21(6):442. doi: 10.3892/ol.2021.12703. Epub 2021 Apr 2.
9
LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.长链非编码 RNA ENST00000539653 通过 MAPK 信号通路在甲状腺乳头状癌中发挥致癌因子的作用。
BMC Cancer. 2019 Apr 2;19(1):297. doi: 10.1186/s12885-019-5533-4.
10
ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.环状 RNA(circRNA) 是一类广泛存在的内源性非编码 RNA,其在生物过程中发挥着重要作用。环状 RNA 可以通过与 microRNA(miRNA)相互作用来调节基因表达,从而影响细胞的增殖、分化和凋亡等过程。 在本研究中,我们发现环状 RNA ciRS-7 在甲状腺癌组织和细胞中高表达。通过过表达和敲低实验,我们发现 ciRS-7 可以促进甲状腺癌细胞的增殖和迁移。机制研究表明,ciRS-7 通过与 miR-7 结合,从而抑制 miR-7 的表达。进一步研究发现,miR-7 可以靶向抑制表皮生长因子受体(EGFR)的表达。因此,ciRS-7 通过负调控 miR-7/EGFR 轴促进甲状腺癌细胞的增殖和迁移。 综上所述,我们的研究结果表明,ciRS-7 可能成为甲状腺癌治疗的一个潜在靶点。
Biomed Res Int. 2020 Jun 21;2020:9875636. doi: 10.1155/2020/9875636. eCollection 2020.

引用本文的文献

1
Comprehensive transcriptome and scRNA-seq analyses uncover the expression and underlying mechanism of SYNJ2 in papillary thyroid carcinoma.综合转录组和单细胞 RNA 测序分析揭示了 SYNJ2 在甲状腺乳头状癌中的表达和潜在机制。
IET Syst Biol. 2024 Oct;18(5):183-198. doi: 10.1049/syb2.12099. Epub 2024 Oct 6.
2
Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer.多组学生殖细胞瘤相关蛋白 2 泛癌研究及其作为胰腺癌潜在治疗靶点的价值。
Sci Rep. 2024 Apr 29;14(1):9764. doi: 10.1038/s41598-024-60780-6.
3
GPX4 inhibits apoptosis of thyroid cancer cells through regulating the FKBP8/Bcl-2 axis.

本文引用的文献

1
, a New Biomarker of Lung Adenocarcinoma.,一种肺腺癌的新型生物标志物。 (你提供的原文似乎不完整,开头缺少具体内容)
Front Oncol. 2021 Oct 20;11:754290. doi: 10.3389/fonc.2021.754290. eCollection 2021.
2
LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.由EP300-SMYD2复合物调控的LINC01605增强了结直肠癌中METTL3与SPTBN2之间的结合。
Cancer Cell Int. 2021 Sep 20;21(1):504. doi: 10.1186/s12935-021-02180-8.
3
A Comprehensive Analysis of the Downregulation of and Its Prognostic Significance by Targeting and in Ovarian Cancer.
GPX4 通过调控 FKBP8/Bcl-2 轴抑制甲状腺癌细胞凋亡。
Cancer Biomark. 2024;39(4):349-360. doi: 10.3233/CBM-230220.
通过靶向 和 对卵巢癌中 下调及其预后意义的综合分析。 (原文中部分关键基因名称缺失,请补充完整后再进行准确理解和完整翻译)
Front Mol Biosci. 2021 Jun 11;8:687576. doi: 10.3389/fmolb.2021.687576. eCollection 2021.
4
Two novel missense variants in SPTBN2 likely associated with spinocerebellar ataxia type 5.两个 SPTBN2 中的新型错义变异可能与脊髓小脑共济失调 5 型相关。
Neurol Sci. 2021 Dec;42(12):5195-5203. doi: 10.1007/s10072-021-05204-3. Epub 2021 Apr 2.
5
Novel SPTBN2 gene mutation and first intragenic deletion in early onset spinocerebellar ataxia type 5.新型 SPTBN2 基因突变及 5 型早发性脊髓小脑共济失调的首个基因内缺失
Ann Clin Transl Neurol. 2021 Apr;8(4):956-963. doi: 10.1002/acn3.51345. Epub 2021 Mar 23.
6
Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.通过 MeRIP 测序对结直肠癌进行全转录组 m6A 甲基组学的综合分析。
Epigenetics. 2021 Apr;16(4):425-435. doi: 10.1080/15592294.2020.1805684. Epub 2020 Aug 12.
7
SPTBN1 and cancer, which links?SPTBN1 与癌症,有何关联?
J Cell Physiol. 2020 Jan;235(1):17-25. doi: 10.1002/jcp.28975. Epub 2019 Jun 17.
8
Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma. spectrins βI 和 βIII 在肝细胞癌诊断中的应用。
Ann Diagn Pathol. 2019 Apr;39:86-91. doi: 10.1016/j.anndiagpath.2019.02.009. Epub 2019 Feb 15.
9
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
10
Signature Gene Identification of Cancer Occurrence and Pattern Recognition.癌症发生的特征基因鉴定与模式识别
J Comput Biol. 2018 Aug;25(8):907-916. doi: 10.1089/cmb.2017.0261. Epub 2018 Jun 29.